Bazedoxifene

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

Breast CancerPancreatic AdenocarcinomaPostmenopausal Osteoporosis

2828 competitors in Breast Cancer

#DrugCompanyPhaseTrials

1

Tecentriq

Roche

Preclinical

362

Trodelvy

Gilead

Preclinical

373

Halaven

Eisai

Preclinical

384

Tykerb

GSK

Preclinical

805

Bazedoxifene

Pfizer

Phase 3

16

Adriamycin

GGynecologic Oncology Group

Preclinical

877

Avastin

BBio-Thera Solutions

Preclinical

1538

Nolvadex

SSan Diego Pacific Oncology & Hematology Associates

Preclinical

789

Prolia

Amgen

Preclinical

1410

Gemzar

GGynecologic Oncology Group

Preclinical

22Show 39 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Postmenopausal Women3 trials

Study Evaluating Potential Drug Interaction Of Bazedoxifene & Premarin In Healthy Postmenopausal Women

Completed·Pfizer·Phase 1·NCT00706225·30 enrolled

Switching From Oral Bisphosphonates to Bazedoxifene to Evaluate Effects on Bone Mineral Density in Postmenopausal Women

Completed·IInstituto Palacios·Phase 4·NCT02090400·110 enrolled

A Pilot Bioavailability Study of 3 Test Tablet Formulations of Bazedoxifene Compared With A Reference Tablet Formulation of Bazedoxifene/Conjugated Estrogens in Healthy Postmenopausal Women

Terminated·Pfizer·Phase 1·NCT01634789·2 enrolled

Postmenopausal Osteoporosis2 trials

Study Evaluating Bazedoxifene Dose-Response in Japanese Patients With Postmenopausal Osteoporosis.

Completed·Pfizer·Phase 2·NCT00238745·375 enrolled

Study Evaluating The Effects Of Bazedoxifene/Conjugated Estrogens On Endometrial Safety And Postmenopausal Osteoporosis

Completed·Pfizer·Phase 3·NCT00808132·1,886 enrolled

Safety and Efficacy1 trial

Study Evaluating the Safety and Efficacy of Bazedoxifene in Postmenopausal Asian Women

Completed·Pfizer·Phase 3·NCT00384072·500 enrolled

Observational Study1 trial

Observational Study Analyzing RNA Expression Of Endometrial Biopsy Samples From Placebo, Bazedoxifene/Conjugated Estrogens And Raloxifene

Terminated·Pfizer··NCT00847821·185 enrolled

Estrogen1 trial

Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens

Active, not recruiting·UUniversity of Kansas Medical Center·Phase 2·NCT04821141·120 enrolled

5 more indications

Glucocorticoid1 trial

Effectiveness of Bazedoxifene for Prevention of Glucocorticoid-induced Bone Loss in RA Patients

Completed·HHanyang University·Phase 4·NCT02602704·114 enrolled

Pancreatic Adenocarcinoma1 trial

Bazedoxifene as a Concomitant Treatment of Patients With Metastatic Pancreatic Adenocarcinoma

Unknown status·HHôpital Fribourgeois·N/A·NCT04812808·10 enrolled

Trial1 trial

HDDO-1614 Intervention Trial

Completed·HHyundai Pharmaceutical Co., LTD.·Phase 1·NCT03234244·37 enrolled

Breast Cancer1 trial

A Study of Palbociclib in Combination With Bazedoxifene in Hormone Receptor Positive Breast Cancer

Completed·—·Phase 1/2·NCT02448771·36 enrolled

Unspecified3 trials

Bazedoxifene Post Approval Safety Study (PASS) in the European Union (EU)

Completed·Pfizer··NCT01416194·10,497 enrolled

AK-R215 Pharmacokinetic Study Phase I

Unknown status·AAlvogen Korea·Phase 1·NCT03321318·52 enrolled

Viviant 20mg Special Investigation (Regulatory Post Marketing Commitment Plan)

Completed·Pfizer··NCT01470326·3,187 enrolled

Details

Drug Info

Related News